SEC Form D · filed August 4, 2020
Kinnate Biopharma Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (21)
Mark W. Meltz · San Diego, CAExecJim W. Tananbaum · San Diego, CADirectorKeith W. Flaherty · San Diego, CADirectorCarl W. Gordon · San Diego, CADirectorNima W. Farzan · San Diego, CAExec · DirectorStephen W. Kaldor · San Diego, CADirector · PromoterMichael W. Rome · San Diego, CADirectorHarbert Stoneview Fund GP, LLC · BIRMINGHAM, ALDirectorSarah Sullivan · Mill Valley, CADirectorFloyd E. Wilson Iii · Mill Valley, CADirectorMark Mennitt · Greenwich, CTDirectorHarbert Management Corporation · BIRMINGHAM, ALDirector · PromoterHarbert Fund Advisors, Inc · BIRMINGHAM, ALExecDax Vlassis · NEW YORK, NYExec · DirectorKarim Faris · Atlanta, GADirectorTed Schlein · Atlanta, GAExecRyan Barretto · Atlanta, GADirectorRon Shah · Atlanta, GADirector · PromoterTerrapin Asset Management, LLC · Miami, FLDirectorTerrapin Realization GP, LLC · Miami, FLDirectorEricka Z. Iachello · New York, NYExec · Director Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗